1. Home
  2. CPIX vs NDLS Comparison

CPIX vs NDLS Comparison

Compare CPIX & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • NDLS
  • Stock Information
  • Founded
  • CPIX 1999
  • NDLS 1995
  • Country
  • CPIX United States
  • NDLS United States
  • Employees
  • CPIX N/A
  • NDLS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • CPIX Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • CPIX Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • CPIX 68.7M
  • NDLS 34.3M
  • IPO Year
  • CPIX 2009
  • NDLS 2013
  • Fundamental
  • Price
  • CPIX $5.15
  • NDLS $1.55
  • Analyst Decision
  • CPIX
  • NDLS Strong Buy
  • Analyst Count
  • CPIX 0
  • NDLS 2
  • Target Price
  • CPIX N/A
  • NDLS $3.00
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • NDLS 326.3K
  • Earning Date
  • CPIX 03-04-2025
  • NDLS 03-06-2025
  • Dividend Yield
  • CPIX N/A
  • NDLS N/A
  • EPS Growth
  • CPIX N/A
  • NDLS N/A
  • EPS
  • CPIX N/A
  • NDLS N/A
  • Revenue
  • CPIX $36,785,442.00
  • NDLS $495,817,000.00
  • Revenue This Year
  • CPIX N/A
  • NDLS $0.28
  • Revenue Next Year
  • CPIX N/A
  • NDLS N/A
  • P/E Ratio
  • CPIX N/A
  • NDLS N/A
  • Revenue Growth
  • CPIX N/A
  • NDLS N/A
  • 52 Week Low
  • CPIX $1.04
  • NDLS $0.55
  • 52 Week High
  • CPIX $6.43
  • NDLS $2.62
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.22
  • NDLS 63.25
  • Support Level
  • CPIX $4.12
  • NDLS $1.44
  • Resistance Level
  • CPIX $5.29
  • NDLS $1.68
  • Average True Range (ATR)
  • CPIX 0.74
  • NDLS 0.15
  • MACD
  • CPIX 0.17
  • NDLS -0.01
  • Stochastic Oscillator
  • CPIX 70.57
  • NDLS 58.14

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: